The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It Mean from a Research-Based Company Perspective?
Antitrust Chronicle, 2008, vol. 11
A sector inquiry is never pleasant for the sector involved. It is much like going to the dentist for a checkup. The best possible result is that after all is said and done, nothing was wrong and life can go on. Well, this checkup began with a bang. On January 16, 2008, the European Commission launched a sector inquiry by staging a series of dawn raids on a number of pharmaceutical companies, with no suggestion of specific wrongdoing. The expressed reasons for the inquiry are puzzling.
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
http://www.competitionpolicyinternational.com/the- ... -company-perspective (application/pdf)
Requires login and subscription
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:cpi:atchrn:11.1.2008:i=5161
Access Statistics for this article
More articles in Antitrust Chronicle from Competition Policy International
Bibliographic data for series maintained by Lindsay McSweeney (). This e-mail address is bad, please contact .